Search results :

Ceftazidime

More information: STITCH, PubChem (stereo-specific compounds: 1, 2) and possibly Wikipedia

ATC Code: J01DD02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10
Diarrhoea common x x x x x x x x x x
Inflammation common x x x x x x x x x
Pain common x x x x x
Phlebitis common x x x x x x x x x x
Thrombophlebitis common x x x x x
Thrombocytosis common x x x x x x x x x
Eosinophilia common, 3.4% x x x x x x x x x
Urticaria postmarketing, common x x x x x x x x x
Abdominal pain uncommon x x x x x x x x x x
Candida infection uncommon x x x x x x x x x x
Oral candidiasis uncommon x x x x x x x x x x
Colitis uncommon x x x x x x x x
Dizziness uncommon x x x x x x x x x x
Body temperature increased uncommon x x x x x x x x x x
Headache uncommon x x x x x x x x x x
Leukopenia uncommon x x x x x x x x x
Nausea uncommon x x x x x x x x x x
Neutropenia uncommon x x x x x x x x x
Pruritus uncommon x x x x x x x x x x
Thrombocytopenia uncommon x x x x x x x x x
Vaginal inflammation uncommon x x x x x x x x x x
Vomiting uncommon x x x x x x x x x x
Aplastic anaemia postmarketing x x x x
Cholestasis postmarketing x x x x
Haemorrhage postmarketing x x x x
Hyperbilirubinaemia postmarketing x x x x
Hypersensitivity postmarketing x x x x x x x x
Nephropathy postmarketing x
Pancytopenia postmarketing x x x x
Renal failure postmarketing x
Hepatic function abnormal postmarketing x x x x
Injection site pain postmarketing x x x x
Prothrombin level increased postmarketing x x x x
Application site pain postmarketing x
Cardio-respiratory arrest postmarketing x x x x
Renal impairment postmarketing x
Anaphylactic shock very rare, postmarketing x x x x x x x x x x
Jaundice very rare, postmarketing x x x x x x x
Agranulocytosis very rare x x x x x x x x
Haemolytic anaemia very rare x x x x x x x x x
Angioedema very rare x x x x x x x x x x
Bronchospasm very rare x x x x x x x x x x
Toxic epidermal necrolysis very rare x x x x x x x x x
Erythema multiforme very rare x x x x x x x x
Hypotension very rare x x x x x x x x x x
Lymphocytosis very rare x x x x x x x x x
Paraesthesia very rare x x x x x x x x x x
Stevens-Johnson syndrome very rare x x x x x x x x
Bad taste very rare x x x x
Coma x x x x x x x x x
Rash x x x x x x
Flushing x
Gastrointestinal disorder x x
Hallucination x
Immune system disorder x x
Lethargy x
Myoclonus x
Nervous system disorder x x
Convulsion x x x x x x x x x x
Tremor x x x x
Angiopathy x x
Encephalopathy x x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue x x
Asterixis x x x x x
Excitability x x x x
Skin exfoliation x
Coombs test positive x x x x x
Hepatobiliary disease x x
Vision blurred x
Gastrointestinal symptom NOS x x x x x
Disulfiram like reaction x x x x
Reaction gastrointestinal x x x x x x
Nephropathy toxic x x x
Hot flush x
Infestation NOS x x
Blood and lymphatic system disorders x x
Local reaction x x x x x x
Foetal damage x
Allergic exanthema x
Pseudomembranous colitis x x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CEFTAZIDIME / CEFTAZIDIME FOR INJECTION, USP

Side effects:34
Source:Health Canada

CEFTAZIDIME / FORTAZ - INJ 1G/VIAL

Side effects:45
Source:Health Canada

ceftazidime pentahydrate / CEFTAZIDIME

Side effects:41
Source:medicines.org.au

CEFTAZIDIME ANHYDROUS

Side effects:47
Source:FDA Structured Product Label

CEFTAZIDIME

Side effects:42
Source:FDA Structured Product Label

CEFTAZIDIME ANHYDROUS

Side effects:54
Source:FDA Structured Product Label

CEFTAZIDIME ANHYDROUS

Side effects:55
Source:FDA Structured Product Label

ceftazidime / Fortaz

Side effects:56
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label